Cargando…

Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa

BACKGROUND: Gauteng Province has the second lowest tuberculosis (TB) incidence rate in South Africa but the greatest proportion of TB/HIV co-infection, with 68% of TB patients estimated to have HIV. TB treatment outcomes are well documented at the national and provincial level; however, knowledge ga...

Descripción completa

Detalles Bibliográficos
Autores principales: Berry, Kaitlyn M., Rodriguez, Carly A., Berhanu, Rebecca H., Ismail, Nazir, Mvusi, Lindiwe, Long, Lawrence, Evans, Denise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647101/
https://www.ncbi.nlm.nih.gov/pubmed/31331311
http://dx.doi.org/10.1186/s12889-019-7257-4
_version_ 1783437655436951552
author Berry, Kaitlyn M.
Rodriguez, Carly A.
Berhanu, Rebecca H.
Ismail, Nazir
Mvusi, Lindiwe
Long, Lawrence
Evans, Denise
author_facet Berry, Kaitlyn M.
Rodriguez, Carly A.
Berhanu, Rebecca H.
Ismail, Nazir
Mvusi, Lindiwe
Long, Lawrence
Evans, Denise
author_sort Berry, Kaitlyn M.
collection PubMed
description BACKGROUND: Gauteng Province has the second lowest tuberculosis (TB) incidence rate in South Africa but the greatest proportion of TB/HIV co-infection, with 68% of TB patients estimated to have HIV. TB treatment outcomes are well documented at the national and provincial level; however, knowledge gaps remain on how outcomes differ across detailed age groups. METHODS: Using data from South Africa’s National Electronic TB Register (ETR), we assessed all-cause mortality and loss to follow-up (LTFU) among patients initiating treatment for TB between 01/2010 and 12/2015 in the metropolitan municipalities of Ekurhuleni Metropolitan Municipality and the City of Johannesburg in Gauteng Province. We excluded patients who were missing age, had known drug-resistance, or transferred into TB care from sites outside the two metropolitan municipalities. Among patients assigned a treatment outcome, we investigated the association between age group at treatment initiation and mortality or LTFU (treatment interruption of ≥2 months) within 10 months after treatment initiation using Cox proportional hazard models and present hazard ratios and Kaplan-Meier survival curves. RESULTS: We identified 182,890 children (<10 years), young adolescent (10–14), older adolescent (15–19), young adult (20–24), adult (25–49), and older adult (≥50) TB cases without known drug-resistance. ART coverage among HIV co-infected patients was highest for young adolescents (64.3%) and lowest for young adults (54.0%) compared to other age groups (all over 60%). Treatment success exceeded 80% in all age groups (n = 170,017). All-cause mortality increased with age. Compared to adults, young adults had an increased hazard of LTFU (20–24 vs 25–49 years; aHR 1.43 95% CI: 1.33, 1.54) while children, young adolescents, and older adults had lower hazard of LTFU. Patients with HIV on ART had a lower risk of LTFU, but greater risk of death when compared to patients without HIV. CONCLUSIONS: Young adults in urban areas of Gauteng Province experience a disproportionate burden of LTFU and low coverage of ART among co-infected patients. This group should be targeted for interventions aimed at improving clinical outcomes and retention in both TB and HIV care.
format Online
Article
Text
id pubmed-6647101
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-66471012019-07-31 Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa Berry, Kaitlyn M. Rodriguez, Carly A. Berhanu, Rebecca H. Ismail, Nazir Mvusi, Lindiwe Long, Lawrence Evans, Denise BMC Public Health Research Article BACKGROUND: Gauteng Province has the second lowest tuberculosis (TB) incidence rate in South Africa but the greatest proportion of TB/HIV co-infection, with 68% of TB patients estimated to have HIV. TB treatment outcomes are well documented at the national and provincial level; however, knowledge gaps remain on how outcomes differ across detailed age groups. METHODS: Using data from South Africa’s National Electronic TB Register (ETR), we assessed all-cause mortality and loss to follow-up (LTFU) among patients initiating treatment for TB between 01/2010 and 12/2015 in the metropolitan municipalities of Ekurhuleni Metropolitan Municipality and the City of Johannesburg in Gauteng Province. We excluded patients who were missing age, had known drug-resistance, or transferred into TB care from sites outside the two metropolitan municipalities. Among patients assigned a treatment outcome, we investigated the association between age group at treatment initiation and mortality or LTFU (treatment interruption of ≥2 months) within 10 months after treatment initiation using Cox proportional hazard models and present hazard ratios and Kaplan-Meier survival curves. RESULTS: We identified 182,890 children (<10 years), young adolescent (10–14), older adolescent (15–19), young adult (20–24), adult (25–49), and older adult (≥50) TB cases without known drug-resistance. ART coverage among HIV co-infected patients was highest for young adolescents (64.3%) and lowest for young adults (54.0%) compared to other age groups (all over 60%). Treatment success exceeded 80% in all age groups (n = 170,017). All-cause mortality increased with age. Compared to adults, young adults had an increased hazard of LTFU (20–24 vs 25–49 years; aHR 1.43 95% CI: 1.33, 1.54) while children, young adolescents, and older adults had lower hazard of LTFU. Patients with HIV on ART had a lower risk of LTFU, but greater risk of death when compared to patients without HIV. CONCLUSIONS: Young adults in urban areas of Gauteng Province experience a disproportionate burden of LTFU and low coverage of ART among co-infected patients. This group should be targeted for interventions aimed at improving clinical outcomes and retention in both TB and HIV care. BioMed Central 2019-07-22 /pmc/articles/PMC6647101/ /pubmed/31331311 http://dx.doi.org/10.1186/s12889-019-7257-4 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Berry, Kaitlyn M.
Rodriguez, Carly A.
Berhanu, Rebecca H.
Ismail, Nazir
Mvusi, Lindiwe
Long, Lawrence
Evans, Denise
Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title_full Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title_fullStr Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title_full_unstemmed Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title_short Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa
title_sort treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in gauteng province, south africa
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647101/
https://www.ncbi.nlm.nih.gov/pubmed/31331311
http://dx.doi.org/10.1186/s12889-019-7257-4
work_keys_str_mv AT berrykaitlynm treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT rodriguezcarlya treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT berhanurebeccah treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT ismailnazir treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT mvusilindiwe treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT longlawrence treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica
AT evansdenise treatmentoutcomesamongchildrenadolescentsandadultsontreatmentfortuberculosisintwometropolitanmunicipalitiesingautengprovincesouthafrica